Trial Details
RECRUITINGBasic Information
| Clinical ID | c27 |
|---|---|
| Identifier | NCT07350577 |
| Trial Title | Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | BIOLOGICAL: ALTB-268|OTHER: Placebo |
Participant Information
| Sponsor | AltruBio Inc. |
|---|---|
| City | Miami |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-11-17 |
|---|---|
| Primary Completion Date | 2026-03-26 |
| Completion Date | 2026-07-28 |